NVCT EBITDA Growth
Nuvectis Pharma Inc · EBITDA Growth
NVCT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-31.05%period ending
NVCT TTM EBITDA YoY % (-48.06% → -31.05%)
Year-over-year change
High-resolution chart · PNG
NVCT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -31.0509% | |
| -39.1598% | |
| -43.8842% | |
| -30.9797% | |
| -4.573% | |
| 9.9232% | |
| 14.6451% | |
| 13.2533% | |
| 5.4993% | |
| -10.8514% | |
| -16.6361% | |
| -52.4505% | |
| -66.1335% | |
| -27.7103% | |
| -48.0605% |